期刊文献+

聚丙烯酸树脂EudragitL100和EudragitS100游离膜性质研究 被引量:4

Properties of Polyacrylic Resin Eudragit L100 and Eudragit S100 Free Film
原文传递
导出
摘要 目的研究聚丙烯酸树脂Eudragit L100和Eudragit S100(1∶4混合)游离膜的性质,考察其影响因素。方法采用铸膜法制备游离膜,测定聚合物溶度参数、特性黏度、抗张强度和透湿性,筛选聚合物最佳溶剂和增塑剂。结果乙醇制成的游离膜抗张强度最大,丙酮制成的游离膜透湿性最强,乙醇为最佳溶剂;增塑剂可降低游离膜的抗张强度和增加膜的透湿性,邻苯二甲酸二乙酯为最佳增塑剂。结论这些研究可以为包衣液处方筛选和包衣工艺优化提供参考。 OBJECTIVE To investigate the properties of polyacrylic resin Eudragit Ll00-Eudragit S100 (mixed at ratio of 1: 4) free film and its various influencing factors. METHODS The free film was prepared by casting method, and its solubility parameter, intrinsic viscosity, tensile strength and permeability were determined. The optimal solvent and plasticizer were screened. RESULTS The tensile strength of the film prepared by ethanol was maximum, and the permeability of the free fihn made using acetone was the highest, therefore ethanol was the optimal solvent. Plasticizer could decrease the tensile strength and increase the permeability of free film, and diethyl phthalate was the optimal plasticizer. CONCLUSION The present investigation might be helpful for screening coat- ing formulation and optimizing coating process.
作者 张双庆
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第18期1489-1492,共4页 Chinese Pharmaceutical Journal
关键词 聚丙烯酸树Eudragit L100 EUDRAGIT S100 游离膜 溶度参数 抗张强度 透湿性 polyacrylic resin Eudragit LIO0 Eudragit SIO0 free film solubility parameter tensile strength permeability
  • 相关文献

参考文献4

  • 1ZHANG S Q,THUMMA S,CHEN G H,et al. In vitro and in vivo evaluation of tegaserod maleate pH-dependant tablets [ J ]. Eur J Pharm Biopharm ,2008,69 ( 1 ) : 247-254.
  • 2王桂玲,张双庆,张毅.包衣工艺参数对马来酸替加色罗pH依赖型缓释片释放度的影响[J].中国实验方剂学杂志,2010,16(3):4-7. 被引量:5
  • 3Peking university college of chemistry department of polymer. PolynerExperimentsandMonograph(高分子实验与专论)[M].Beijing:Peking University Press,1990:505-508.
  • 4Lu B.New Techniques and New Dosage Forms of Drugs(药物新剂型与新技术)[M].Beijing:People's Medical Publishing House,1998:114.

二级参考文献4

  • 1Rivkin A. Tegaserod maleate in the treatment of irritable bowel syndrome: a clinical review[ J]. Clin Ther, 2003, 25(7) : 1952.
  • 2Wagstaff A J, Frampton JE, Croom KF. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women[ J]. Drugs, 2003, 63 (11) :1101.
  • 3Zhang SQ, Thumma S, Chen GH, et al. In vitro and in vivo evaluation of tegaserod maleate pH-dependant tablets [J]. Eur J Pharm Biopharm, 2008, 69(1 ): 247.
  • 4国家药典委员会.中华人民共和国药典[S].第二部,北京:化学工业出版社,2005:附录74.

共引文献6

同被引文献24

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部